title: Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
abstract: Meningiomas are benign tumors of the central nervous system. They are usually sporadic but can also occur associated with the neurofibromatosis type 2 (NF2) syndrome. The gene responsible for NF2, recently isolated from chromosome 22, encodes a membrane-organizing protein that shows high sequence homology to a protein family thought to link the cytoskeleton with membrane proteins. Mutations of the NF2gene have been described in sporadic meningiomas, exclusively in tumors that show loss of heterozygosity (LOH) of 22q. These preliminary results indicate that the NF2 gene is involved in the pathogenesis of at least a subset of meningiomas, where it does indeed behave as a tumor suppressor gene. In order to characterize better the role of the NF2 gene in the genesis of meningiomas we have examined the entire coding sequence of the gene in 125 meningiomas by single-strand conformational polymorphism analysis; furthermore, LOH analysis for markers of 22q has been carried out. Inactivating mutations were identified in 30% of our samples, all of which also showed LOH of 22q. The majority of mutations identified were frameshifts and nonsense mutations, which are predicted to produce a truncated or nonfunctional protein. We also found two missense and three in-frame deletions that may pinpoint specific regions of the protein critical to its function. Furthermore, the distribution of mutations throughout the gene, suggested that exons 2, 3, 5, 11 and 13 are more frequently involved. Our results reconfirm the importance of the NF2 gene in the pathogenesis of meningiomas and also suggest that there may be a nonrandom clustering of mutations throughout the gene.
authors.affiliation: Medical Genetics Unit, Department of Clinical Physiopathology, University of Florence, Italy.
authors.forename: L R
authors.initials: LR
authors.lastname: De Vitis
authors.forename: A
authors.initials: A
authors.lastname: Tedde
authors.forename: F
authors.initials: F
authors.lastname: Vitelli
authors.forename: F
authors.initials: F
authors.lastname: Ammannati
authors.forename: P
authors.initials: P
authors.lastname: Mennonna
authors.forename: U
authors.initials: U
authors.lastname: Bigozzi
authors.forename: E
authors.initials: E
authors.lastname: Montali
authors.forename: L
authors.initials: L
authors.lastname: Papi
mesh_terms: D001483:Base Sequence; D002872:Chromosome Deletion; D002892:Chromosomes, Human, Pair 22; D004247:DNA / Q000097:blood; D017931:DNA Primers; D004273:DNA, Neoplasm / Q000032:analysis; D005091:Exons; D016368:Frameshift Mutation; D016515:Genes, Neurofibromatosis 2; D006801:Humans; D007438:Introns; D008577:Meningeal Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D008579:Meningioma / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D008969:Molecular Sequence Data; D009154:Mutation; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D017384:Sequence Deletion
chemical_list: D017931:DNA Primers; D004273:DNA, Neoplasm; D004247:DNA